Skip to Content
Merck
CN
  • Comparative analysis of ginsenosides in human glucocorticoid receptor binding, transactivation, and transrepression.

Comparative analysis of ginsenosides in human glucocorticoid receptor binding, transactivation, and transrepression.

European journal of pharmacology (2017-10-17)
Catherine Hu, Aik Jiang Lau, RuiQi Wang, Thomas K H Chang
ABSTRACT

Conflicting data exist on the effect of ginsenosides on transactivation of human glucocorticoid receptor α (herein referred to as glucocorticoid receptor), and relatively little is known regarding the effect of these chemicals on transrepression of this receptor. We investigated the effect of 20(S)-protopanaxadiol (PPD), PPD-type ginsenosides (Rb1, Rb2, Rc, Rd, Rh2, and Compound K), 20(S)-protopanaxatriol (PPT), and PPT-type ginsenosides (Re, Rf, Rg1, and Rh1) on glucocorticoid receptor binding, transactivation, and transrepression. Each ginsenoside was less efficacious than dexamethasone (positive control) in binding to the ligand-binding domain of glucocorticoid receptor. Among the ginsenosides investigated, Rh2 had the smallest IC

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Ginsenoside Compound K, ≥96% (HPLC)